WallStreetZenWallStreetZen

NASDAQ: KALV
Kalvista Pharmaceuticals Inc Stock Ownership - Who owns Kalvista Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Kalvista Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Benjamin L. PalleikoCHIEF EXECUTIVE OFFICER2026-03-096,693$16.08
$107.63kSell
Nicole SweenyChief Commercial Officer2026-02-233,975$15.57
$61.88kSell
Paul K. AudhyaCHIEF MEDICAL OFFICER2026-02-235,354$15.57
$83.35kSell
Benjamin L. PalleikoCHIEF EXECUTIVE OFFICER2026-02-2310,034$15.57
$156.20kSell
Brian PiekosChief Financial Officer2026-02-231,767$15.57
$27.51kSell
Christopher YeaCHIEF DEVELOPMENT OFFICER2026-02-234,347$15.57
$67.67kSell
Benjamin L. PalleikoCHIEF EXECUTIVE OFFICER2026-02-181,038$15.00
$15.57kSell
Christopher YeaCHIEF DEVELOPMENT OFFICER2026-02-181,109$15.00
$16.64kSell
Paul K. AudhyaCHIEF MEDICAL OFFICER2026-02-181,163$15.00
$17.45kSell
Benjamin L. PalleikoCHIEF EXECUTIVE OFFICER2026-02-123,354$15.70
$52.66kSell

1 of 5

KALV insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KALV insiders and whales buy or sell their stock.

KALV Shareholders

What type of owners hold Kalvista Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vivo Ventures VI LLC16.64%8,409,126$139.59MInsider
Vr Adviser LLC13.31%6,728,985$111.70MInstitution
Venrock Healthcare Capital Partners III LP10.49%5,303,985$88.05MInsider
Frazier Life Sciences Management LP9.97%5,039,867$83.66MInstitution
Suvretta Capital Management LLC9.43%4,768,712$79.16MInstitution
Interwest Management Partners IX LLC9.14%4,619,196$76.68MInsider
Tang Capital Management LLC9.05%4,573,530$75.92MInstitution
Acmp IV LLC8.59%4,343,550$72.10MInsider
Guy P. Nohra8.59%4,343,550$72.10MInsider
Blackrock Inc7.43%3,754,148$62.32MInstitution

1 of 3

KALV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KALV62.13%37.87%Net SellingNet Selling
GHRS75.07%0.00%
CGEM56.33%43.67%Net BuyingNet Selling
JANX62.03%37.97%Net SellingNet Selling
ABUS30.49%69.51%
View Top Biotech Stocks

Kalvista Pharmaceuticals Stock Ownership FAQ

Who owns Kalvista Pharmaceuticals?

Kalvista Pharmaceuticals (NASDAQ: KALV) is owned by 132.46% institutional shareholders, 80.74% Kalvista Pharmaceuticals insiders, and 0.00% retail investors. Vivo Ventures VI LLC is the largest individual Kalvista Pharmaceuticals shareholder, owning 8.41M shares representing 16.64% of the company. Vivo Ventures VI LLC's Kalvista Pharmaceuticals shares are currently valued at $138.41M.

If you're new to stock investing, here's how to buy Kalvista Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.